To view this email as a web page, click
here.
|
Advertisement |
_1785202.jpg) |
|
|
|
|
|
Racial differences in genetic mutations were observed among patients with early-onset colorectal cancer, according to data presented by Andreana N. Holowatyj, PhD, MS, during the virtual AACR Annual Meeting 2021.
Women diagnosed with ovarian cancer were more than three times more likely than the general public to be diagnosed with anxiety, depression, and adjustment disorder, according to results presented by Hu et al during the virtual AACR Annual Meeting 2021.
Karen E. Knudsen, MBA, PhD, will be the next Chief Executive Officer of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network, starting June 1, 2021. Dr. Knudsen will be the 107-year-old organization's first female Chief Executive Officer.
In a long-term follow-up of a National Cancer Institute phase I trial reported in the Journal of Clinical Oncology, Nirali N. Shah, MD, and colleagues found that autologous CD19 chimeric antigen receptor (CAR) T-cell therapy followed by allogeneic hematopoietic stem cell transplantation can produce prolonged disease control in a substantial proportion of children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL).
In a Canadian study reported in JAMA Surgery, Hallet et al found that higher anesthesiologist volume was associated with reduced risk of short-term adverse postoperative outcomes in patients undergoing complex surgery for gastrointestinal cancer.
|
|
Advertisement |
|
|
The AACR Annual Meeting 2021 launched week 1 of a 2-week program on April 10, featuring plenary sessions and major scientific symposia. In this week's podcast, The ASCO Post speaks with faculty from the meeting who presented clinical research in non–small cell lung cancer, non-Hodgkin lymphoma, and uveal melanoma.
|
Advertisement
|
|
|
NEWSREELS FROM THE AACR Annual Meeting 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
Visit The ASCO Post Online at ASCOPost.com
Or
Visit and Follow Us
|
|
The ASCO Post™ is published by Harborside Press, LLC under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in The ASCO Post™ do not necessarily reflect those of Harborside Press, LLC, HSP News Service, LLC, or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Harborside Press, HSP News Service, LLC, and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions. |
|
|
|
|
INSERT_DYNAMIC_CONTENT_BLOCK_34492 |
|